LATEST ALERTS
The European Food Safety Authority denies it is waiting research results on the safety of CBD by the US Food and Drug Administration before it lets validated candidates complete the novel food application process
US company 22nd Century Group has acquired privately held UK cannabinoid distributor RX Pharmatech for an up-front payment of $650,000 in cash and stock
The US Food and Drug Administration (FDA) has issued a final guidance document for the development of medical drugs containing cannabis
The US Food and Drug Administration (FDA) has rejected a regulatory pathway that would allow CBD products to be treated as food additives or dietary supplements
Government and industry representatives from around the world met in Geneva last week to hear about the “significant economic opportunities” offered by industrial hemp and the need for greater clarity on its legal status
Licensed medical cannabis patients in the US state of Georgia can legally possess oils with less than 5% THC, but they can’t legally buy it due to legislative delays and a series of legal appeals
Belgium has set new rules for nicotine-free e-liquids, effectively banning all e-liquids containing CBD – and thereby setting up a possible conflict with EU law
This report provides a detailed overview of the current regulatory framework in place in Russia for hemp, CBD and cannabis, covering all areas of policy
Legislation to create a medical cannabis programme in the US state of Kansas appeared to be on the verge of success many times – but it died again as the 2022 session drew to a close
Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
